Why the study?
Does salicylate prevent coronary artery abnormalities in children with Kawasaki disease?
Population
Children with Kawasaki disease (review included 1 trial with n=102 children and a second comparative study)
Comparison
Salicylate (acetylsalicylic acid, aspirin) vs Low dose salicylate or standard therapy without…
Design
Systematic_review
Authors
Loading...
Insufficient evidence to guide ASA addition to IVIG in Kawasaki disease; leaves open need for larger RCTs on coronary outcomes.
Does salicylate prevent coronary artery abnormalities in children with Kawasaki disease?
There is currently insufficient high-quality randomized evidence to determine whether salicylate is effective in preventing coronary artery abnormalities in children with Kawasaki disease.
Baumer et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: